logo

For the Inventor, By the Inventor

St. Laurent, Canada

Intelgenx Corporation


USPTO Granted Patents = 21

% Expired Patents = 9.5



Trademarks = 3

Forward Citations = 267

Loading Chart...
Loading Chart...

15 inventors (with patents filed for the assignee):

goldMedal Nadine Paiement (20 out of 22 patents)

silverMedal Rodolphe Obeid (13 out of 13 patents)

bronzeMedal Horst G Zerbe (10 out of 13 patents)

4.  Justin W Conway (7 out of 8 patents)

5.  Erick Gonzalez-Labrada (4 out of 4 patents)

6.  Billal Tir (4 out of 4 patents)

7.  Angela Angusti (3 out of 3 patents)

8.  Cormac Long (2 out of 2 patents)

9.  Ludwig Aigner (2 out of 9 patents)

10.  Carolin Madwar (2 out of 2 patents)

11.  Laetitia Rodes (1 out of 1 patent)

12.  Pompilia Lspas-Szabo (1 out of 1 patent)

13.  Fadia Al-Khalil (1 out of 3 patents)

14.  Mobarik Bilal (1 out of 1 patent)

15.  Mobarik Bilal (1 out of 1 patent)


21 patents:

1. 12440472 - Stable tryptamine oral films (2025-10-14),
2. 12303501 - Lipophilic active oral film formulation and method of making the same (2025-05-20),
3. 12156937 - Oral film formulation for modulating absorption profile (2024-12-03),
4. 11957785 - Film dosage form with extended release mucoadhesive particles (2024-04-16),
5. 11648212 - Loxapine film oral dosage form (2023-05-16),
6. 11602504 - Lipophilic active oral film formulation and method of making the same (2023-03-14),
7. 11471406 - Oral film formulation for modulating absorption profile (2022-10-18),
8. 11033493 - Film dosage form with extended release mucoadhesive particles (2021-06-15),
9. 10828254 - Oral film formulation for modulating absorption profile (2020-11-10),
10. 10722476 - Device and method of treating conditions associated with neuroinflammation (2020-07-28),
11. 10610528 - Solid oral film dosage forms and methods for making same (2020-04-07),
12. 10272038 - Film dosage form with extended release mucoadhesive particles (2019-04-30),
13. 9949934 - Device and method of treating conditions associated with neuroinflammation (2018-04-24),
14. 9717682 - Solid oral film dosage forms and methods for making same (2017-08-01),
15. 9668970 - Film dosage form with extended release mucoadhesive particles (2017-06-06),
Company Overview
Intelgenx Corporation is a pharmaceutical company based in St. Laurent, Canada, specializing in the development of innovative drug delivery systems. The company focuses on oral thin film technologies, which enhance the bioavailability and patient compliance of various therapeutic compounds. Intelgenx is dedicated to advancing its proprietary platforms to create effective treatments across multiple therapeutic areas, including pain management and central nervous system disorders, leveraging its expertise in formulation science and drug development.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

21 Patents

#7 in St. Laurent

#685 in Canada

#29,961 in the World

St. Laurent, CA
St. Laurent, Canada

Intelgenx Corporation

Forward Citations = 267

15 inventors:

goldMedal Nadine Paiement (20 out of 22 patents)

silverMedal Rodolphe Obeid (13 out of 13 patents)

bronzeMedal Horst G Zerbe (10 out of 13 patents)

4.  Justin W Conway (7 out of 8 patents)

5.  Erick Gonzalez-Labrada (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Intelgenx Corporation. Retrieved from https://idiyas.com/company/intelgenx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…